RUNX2 and neoplasm: In fact, our findings suggest that nuclear delivery of E-cadherin, particularly at the G2/M stage, can more effectively down-regulate Fam50a expression, resulting in less nuclear translocation of the Fam50a/Runx2 complexes and lower transcription of MMP13 compared to G1-, S-phase tumor cells or untreated tumor cells.